Skeletal muscle cell MHC I expression: implications for statin-induced myopathy

Muscle Nerve. 2010 Feb;41(2):179-84. doi: 10.1002/mus.21479.

Abstract

Statins can induce necrotizing or inflammatory myopathies in some patients. Increased major histocompatibility complex class I (MHC I) expression has been shown in muscle biopsies of statin-induced myopathy. Therefore, we investigated the effect of statins on the expression of MHC I in muscle cells. Using flow cytometry and polymerase chain reaction (PCR), the rhabdomyosarcoma cell line TE671 and primary cultured skeletal muscle cells (SKMC) were investigated for MHC I expression after incubation with different statins and/or interferon-gamma (IFN-gamma). TE671 and SKMC express MHC I in the untreated condition. Statins alone reduced the expression of MHC I in SKMC and had no effect on MHC I in TE671 cells. Statins potentiated the MHC I-inducing effect of IFN-gamma in TE671, but not in SKMC, neither at the protein level nor at the mRNA level. The increased muscle MHC I expression in statin-induced myopathy might not be induced directly by statins themselves.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Cells, Cultured
  • Gene Expression Regulation / drug effects
  • Genes, MHC Class I / physiology
  • HLA Antigens / metabolism*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology
  • Interferon-gamma / pharmacology
  • Muscle Neoplasms / metabolism
  • Muscle Neoplasms / pathology
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / metabolism*
  • Muscle, Skeletal / pathology
  • Muscular Diseases / chemically induced*
  • Muscular Diseases / metabolism*
  • Muscular Diseases / pathology
  • Rhabdomyosarcoma / metabolism
  • Rhabdomyosarcoma / pathology

Substances

  • HLA Antigens
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Interferon-gamma